Literature DB >> 9144580

Differential expression of tenascin-C and tenascin-X in human astrocytomas.

K Hasegawa1, T Yoshida, K Matsumoto, K Katsuta, S Waga, T Sakakura.   

Abstract

Tenascins (TNs) are a family of extracellular matrix glycoproteins. The first member of this family to be recognized, tenascin-C (TN-C), is known to be expressed in various tumors including human astrocytomas. Tenascin-X (TN-X) is the latest member of the TN family to be reported, and its expression in tumor tissues has not yet been examined. In this study, we found expression of TN-X in glioma cell lines and human astrocytomas by immunoblot analysis using anti-mouse TN-X antibodies. We also examined the expression of TN-C and TN-X immunohistochemically in a series of 32 human astrocytomas and tissue from 5 normal brains. Expression of TN-X was up-regulated to a higher degree in low-grade astrocytomas than in high-grade astrocytomas. TN-X was mainly localized in the perivascular stroma around tumor vessels, and weakly expressed in the intercellular spaces among tumor cells. In contrast, TN-C was more strongly expressed in the intercellular spaces and in tumor vessels in high-grade astrocytomas (anaplastic astrocytomas and glioblastomas) than in low-grade astrocytomas. In the tissues expressing both TNs, the distribution of TN-X was often reciprocal to that of TN-C. These findings indicate that the expression of TN-C and TN-X in astrocytomas is different, and that these glycoproteins could be involved in neovascularization in different manners.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144580     DOI: 10.1007/s004010050636

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

1.  A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.

Authors:  Zhi Zeng; Marina Hincapie; Sharon J Pitteri; Samir Hanash; Joost Schalkwijk; Jason M Hogan; Hong Wang; William S Hancock
Journal:  Anal Chem       Date:  2011-05-23       Impact factor: 6.986

Review 2.  Role of Matricellular Proteins in Disorders of the Central Nervous System.

Authors:  A R Jayakumar; A Apeksha; M D Norenberg
Journal:  Neurochem Res       Date:  2016-11-23       Impact factor: 3.996

Review 3.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

4.  Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.

Authors:  Kalembeyi Ilunga; Rika Nishiura; Hiroyasu Inada; Amro El-Karef; Kyoko Imanaka-Yoshida; Teruyo Sakakura; Toshimichi Yoshida
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

Review 5.  Revisiting the Tenascins: Exploitable as Cancer Targets?

Authors:  Richard P Tucker; Martin Degen
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

6.  Tenascin-C Prevents Articular Cartilage Degeneration in Murine Osteoarthritis Models.

Authors:  Yuriyo Matsui; Masahiro Hasegawa; Takahiro Iino; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Akihiro Sudo
Journal:  Cartilage       Date:  2016-12-04       Impact factor: 4.634

7.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

8.  A mouse model of uterine leiomyosarcoma.

Authors:  Katerina Politi; Matthias Szabolcs; Peter Fisher; Ana Kljuic; Thomas Ludwig; Argiris Efstratiadis
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

9.  Identification of the novel localization of tenascinX in the monkey choroid plexus and comparison with the mouse.

Authors:  K Imura; I Sato
Journal:  Eur J Histochem       Date:  2009-12-29       Impact factor: 3.188

10.  TNIIIA2, The Peptide of Tenascin-C, as a Candidate for Preventing Articular Cartilage Degeneration.

Authors:  Tetsuya Hattori; Masahiro Hasegawa; Hironori Unno; Takahiro Iino; Fumio Fukai; Toshimichi Yoshida; Akihiro Sudo
Journal:  Cartilage       Date:  2020-03-23       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.